Loading…
Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy
The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) a...
Saved in:
Published in: | Frontiers in medicine 2017-07, Vol.4, p.102-102 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763 |
---|---|
cites | cdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763 |
container_end_page | 102 |
container_issue | |
container_start_page | 102 |
container_title | Frontiers in medicine |
container_volume | 4 |
creator | Mukhi, Dhanunjay Nishad, Rajkishor Menon, Ram K Pasupulati, Anil Kumar |
description | The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN. |
doi_str_mv | 10.3389/fmed.2017.00102 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1d0d5828a4754de2b267f9087ab75fe9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1d0d5828a4754de2b267f9087ab75fe9</doaj_id><sourcerecordid>1924590080</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</originalsourceid><addsrcrecordid>eNpVkcFPHCEUh0nTphr13FvDsZddH8wwQA9NjLa6ibFN2ia9EQYe7piZYQqzNvvfl3XV6Any-PG9Bx8hHxgsq0rp0zCgX3JgcgnAgL8hh5zrZqGE-vP2xf6AnOR8ByVTcVGz6j054ErWiilxSH7exHvs6ZmbuzhmGgO9TPHfvKZXMQ1xRNqN9Ef00W1nzJ_papj6ztl9OMRELzrb4tw5eoPTOsXJzuvtMXkXbJ_x5HE9Ir-_ff11frW4_n65Oj-7Xrha6HmhKwi2AcVBah0cZ7WAVgeNHCXWSotQCYWCt42y4L32rfdtLZFpVqqyqY7Ias_10d6ZKXWDTVsTbWceCjHdGpvKbD0a5sELxZWtpag98pY3MmhQ0rZSBNSF9WXPmjZt-VaH45xs_wr6-mTs1uY23hshoAFZF8CnR0CKfzeYZzN02WHf2xHjJhumeXk1gIISPd1HXYo5JwzPbRiYnVmzM2t2Zs2D2XLj48vpnvNPHqv_Mkuf9A</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1924590080</pqid></control><display><type>article</type><title>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</title><source>PubMed Central</source><creator>Mukhi, Dhanunjay ; Nishad, Rajkishor ; Menon, Ram K ; Pasupulati, Anil Kumar</creator><creatorcontrib>Mukhi, Dhanunjay ; Nishad, Rajkishor ; Menon, Ram K ; Pasupulati, Anil Kumar</creatorcontrib><description>The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN.</description><identifier>ISSN: 2296-858X</identifier><identifier>EISSN: 2296-858X</identifier><identifier>DOI: 10.3389/fmed.2017.00102</identifier><identifier>PMID: 28748185</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>dedifferentiation ; diabetic nephropathy ; growth hormone ; hypertrophy ; Medicine ; podocytes ; zinc finger E-box binding homeobox2</subject><ispartof>Frontiers in medicine, 2017-07, Vol.4, p.102-102</ispartof><rights>Copyright © 2017 Mukhi, Nishad, Menon and Pasupulati. 2017 Mukhi, Nishad, Menon and Pasupulati</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</citedby><cites>FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506074/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506074/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28748185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mukhi, Dhanunjay</creatorcontrib><creatorcontrib>Nishad, Rajkishor</creatorcontrib><creatorcontrib>Menon, Ram K</creatorcontrib><creatorcontrib>Pasupulati, Anil Kumar</creatorcontrib><title>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</title><title>Frontiers in medicine</title><addtitle>Front Med (Lausanne)</addtitle><description>The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN.</description><subject>dedifferentiation</subject><subject>diabetic nephropathy</subject><subject>growth hormone</subject><subject>hypertrophy</subject><subject>Medicine</subject><subject>podocytes</subject><subject>zinc finger E-box binding homeobox2</subject><issn>2296-858X</issn><issn>2296-858X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkcFPHCEUh0nTphr13FvDsZddH8wwQA9NjLa6ibFN2ia9EQYe7piZYQqzNvvfl3XV6Any-PG9Bx8hHxgsq0rp0zCgX3JgcgnAgL8hh5zrZqGE-vP2xf6AnOR8ByVTcVGz6j054ErWiilxSH7exHvs6ZmbuzhmGgO9TPHfvKZXMQ1xRNqN9Ef00W1nzJ_papj6ztl9OMRELzrb4tw5eoPTOsXJzuvtMXkXbJ_x5HE9Ir-_ff11frW4_n65Oj-7Xrha6HmhKwi2AcVBah0cZ7WAVgeNHCXWSotQCYWCt42y4L32rfdtLZFpVqqyqY7Ias_10d6ZKXWDTVsTbWceCjHdGpvKbD0a5sELxZWtpag98pY3MmhQ0rZSBNSF9WXPmjZt-VaH45xs_wr6-mTs1uY23hshoAFZF8CnR0CKfzeYZzN02WHf2xHjJhumeXk1gIISPd1HXYo5JwzPbRiYnVmzM2t2Zs2D2XLj48vpnvNPHqv_Mkuf9A</recordid><startdate>20170712</startdate><enddate>20170712</enddate><creator>Mukhi, Dhanunjay</creator><creator>Nishad, Rajkishor</creator><creator>Menon, Ram K</creator><creator>Pasupulati, Anil Kumar</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170712</creationdate><title>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</title><author>Mukhi, Dhanunjay ; Nishad, Rajkishor ; Menon, Ram K ; Pasupulati, Anil Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>dedifferentiation</topic><topic>diabetic nephropathy</topic><topic>growth hormone</topic><topic>hypertrophy</topic><topic>Medicine</topic><topic>podocytes</topic><topic>zinc finger E-box binding homeobox2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mukhi, Dhanunjay</creatorcontrib><creatorcontrib>Nishad, Rajkishor</creatorcontrib><creatorcontrib>Menon, Ram K</creatorcontrib><creatorcontrib>Pasupulati, Anil Kumar</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mukhi, Dhanunjay</au><au>Nishad, Rajkishor</au><au>Menon, Ram K</au><au>Pasupulati, Anil Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy</atitle><jtitle>Frontiers in medicine</jtitle><addtitle>Front Med (Lausanne)</addtitle><date>2017-07-12</date><risdate>2017</risdate><volume>4</volume><spage>102</spage><epage>102</epage><pages>102-102</pages><issn>2296-858X</issn><eissn>2296-858X</eissn><abstract>The kidney regulates water, electrolyte, and acid-base balance and thus maintains body homeostasis. The kidney's potential to ensure ultrafiltered and almost protein-free urine is compromised in various metabolic and hormonal disorders such as diabetes mellitus (DM). Diabetic nephropathy (DN) accounts for ~20-40% of mortality in DM. Proteinuria, a hallmark of renal glomerular diseases, indicates injury to the glomerular filtration barrier (GFB). The GFB is composed of glomerular endothelium, basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells with limited ability to replicate. Podocyte shape and number are both critical for the integrity and function of the GFB. Podocytes are vulnerable to various noxious stimuli prevalent in a diabetic milieu that could provoke podocytes to undergo changes to their unique architecture and function. Effacement of podocyte foot process is a typical morphological alteration associated with proteinuria. The dedifferentiation of podocytes from epithelial-to-mesenchymal phenotype and consequential loss results in proteinuria. Poorly controlled type 1 DM is associated with elevated levels of circulating growth hormone (GH), which is implicated in the pathophysiology of various diabetic complications including DN. Recent studies demonstrate that functional GH receptors are expressed in podocytes and that GH may exert detrimental effects on the podocyte. In this review, we summarize recent advances that shed light on actions of GH on the podocyte that could play a role in the pathogenesis of DN.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>28748185</pmid><doi>10.3389/fmed.2017.00102</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2296-858X |
ispartof | Frontiers in medicine, 2017-07, Vol.4, p.102-102 |
issn | 2296-858X 2296-858X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_1d0d5828a4754de2b267f9087ab75fe9 |
source | PubMed Central |
subjects | dedifferentiation diabetic nephropathy growth hormone hypertrophy Medicine podocytes zinc finger E-box binding homeobox2 |
title | Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Actions%20of%20Growth%20Hormone%20in%20Podocytes:%20Implications%20for%20Diabetic%20Nephropathy&rft.jtitle=Frontiers%20in%20medicine&rft.au=Mukhi,%20Dhanunjay&rft.date=2017-07-12&rft.volume=4&rft.spage=102&rft.epage=102&rft.pages=102-102&rft.issn=2296-858X&rft.eissn=2296-858X&rft_id=info:doi/10.3389/fmed.2017.00102&rft_dat=%3Cproquest_doaj_%3E1924590080%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c459t-930fa60820799fc21450b9f9e2e7e4895f358e52b68a0dd9dbddb47e191e52763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1924590080&rft_id=info:pmid/28748185&rfr_iscdi=true |